SOMATEC PHARMACEUTICALS LTD.

Monthly examination for MSO/SMSO

Name: Designation: Market: Region: Time: 30 Minutes. Date: 30/04/12
_____________________________________________________________________________________________________________________________________________________________________

Total Marks M O a bt r ai k n s

20

OME
Q1: Write down the product positioning of OME
Ans: Heart Burn, Erosive Esophagitis Peptic Ulcer Prevention of NSAIDs induced ulcer

02

Q2: Write down at least four key selling points of OME

Ans: FDA approved as OTC for heart burn Safe and effective for control of reflux esophagitis Prevents NSAIDs induced ulcer effectively Ensures patients compliance with treatment success

02

Q3: Omeprazole (OME) has got the FDA approval as OTC drug for Heartburn

01

OSTOFLEX
Q4: Write down the product positioning and target doctor of Ostoflex respectively Ans:
Osteoarthritis Rheumatoid arthritis Ankylosing spondylitis Dental Pain Musculoskeletal pain Gynaecological Pain Post-traumatic Pain Acute lumbago

04

Q5: Aceclofenac (Ostoflex) helps/stimulates cartilage matrix synthesis

01

TGOCEF
Q6 : Write down the Product positioning of Tgocef Ans: AECB, Pneumonia, MDR Typhoid fever, UTIs. Q7: Tgocef (Cefixime) is ideal choice for switch therapy Q8: Pediatric dose of Tgocef in MDR typhoid fever is 10mg/kg 12 hrsly Q9: Write down the two key selling points of Tgocef Ans: Ensure patients benefit with economic & effective therapy Ideal candidate for switch therapy 02

01 01 01

Calmet-D
Q10. What are the indications of Calmet-D? Ans:
Osteoporosis Osteomalacia Bone Fracture Rickets

02

Q11. Why Vitamin D3 is added to Calcium preparation? Ans: Vitamin D3 increases the absorption of Calcium Q12. Write down the key selling point of Calmet-D Ans:
Decreases non-vertebral fracture Right choice in reducing women hip fracture Builds and maintain the foundation of bone Meets calcium demand of fetus, neonate and mother effectively

01 02